Related Experiment Video
Updated: Oct 21, 2025

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
Secreted Frizzled Related Proteins in Cardiovascular and Metabolic Diseases
Hua Guan1,2, Jin Zhang3, Jing Luan1,4
1State Key Laboratory of Military Stomatology & National Clinical Research Center for Oral Diseases & Shaanxi Engineering Research Center for Dental Materials and Advanced Manufacture, Department of Anethesiology, School of Stomatology, Fourth Military Medical University, Xi'an, China.
Abstract:
Abnormal gene expression and secreted protein levels are accompanied by extensive pathological changes. Secreted frizzled related protein (SFRP) family members are antagonistic inhibitors of the Wnt signaling pathway, and they were recently found to be involved in the pathogenesis of a variety of metabolic diseases, which has led to extensive interest in SFRPs. Previous reports highlighted the importance of SFRPs in lipid metabolism, obesity, type 2 diabetes mellitus and cardiovascular diseases. In this review, we provide a detailed introduction of SFRPs, including their structural characteristics, receptors, inhibitors, signaling pathways and metabolic disease impacts. In addition to summarizing the pathologies and potential molecular mechanisms associated with SFRPs, this review further suggests the potential future use of SFRPs as disease biomarkers therapeutic targets.
Insights
Secreted frizzled related proteins (SFRPs) are key regulators of Wnt signaling implicated in metabolic diseases. This review details SFRPs
Area of Science:
- Molecular Biology
- Endocrinology
- Biochemistry
Background:
- Abnormal gene expression and protein levels correlate with pathological changes.
- Secreted frizzled related proteins (SFRPs) antagonize the Wnt signaling pathway.
- SFRPs are increasingly recognized for their role in metabolic disease pathogenesis.
Purpose of the Study:
- To provide a comprehensive overview of SFRPs.
- To explore SFRPs' structural characteristics, receptors, inhibitors, and signaling pathways.
- To examine SFRPs' impact on metabolic diseases like obesity, type 2 diabetes, and cardiovascular conditions.
Main Methods:
- Literature review of existing research on SFRPs.
- Analysis of structural and functional properties of SFRP family members.
- Synthesis of data on SFRPs' involvement in metabolic disease pathologies and molecular mechanisms.
Main Results:
- SFRPs play a significant role in lipid metabolism, obesity, type 2 diabetes mellitus, and cardiovascular diseases.
- Detailed insights into the molecular mechanisms underlying SFRPs' involvement in metabolic disorders.
- Identification of SFRPs' structural features, interactions, and pathway modulation.
Conclusions:
- SFRPs are crucial in regulating metabolic processes and are implicated in various metabolic diseases.
- SFRPs hold potential as therapeutic targets for metabolic diseases.
- SFRPs may serve as valuable biomarkers for diagnosing and monitoring metabolic conditions.
Related Concept Videos
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Cholesterol: Significance and Regulation
Considering cholesterol and...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...

